iSpecimen Inc. (ISPC) News
Filter ISPC News Items
ISPC News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest ISPC News From Around the Web
Below are the latest news stories about ISPECIMEN INC that investors may wish to consider to help them evaluate ISPC as an investment opportunity.
iSpecimen Inc. (NASDAQ:ISPC) Q3 2023 Earnings Call TranscriptiSpecimen Inc. (NASDAQ:ISPC) Q3 2023 Earnings Call Transcript November 3, 2023 Operator: Good day, everyone, and welcome to iSpecimens Third Quarter 2020 Results Conference Call. At this time, participants are in listen-only mode. Question-and-answer session will follow management’s remarks. This conference call is being recorded. A replay of today’s call will be available on the […] |
iSpecimen Reports Third Quarter 2023 Financial and Operating ResultsSequential Quarterly Revenue Growth of 75% Driven by Enhanced Operational Efficiencies of iSpecimen Marketplace and Rollout of New Business InitiativesLEXINGTON, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today reported its financial and operating results for the three and nine month periods |
iSpecimen Expands Proprietary Provider Network to Help Advance Infectious Disease ResearchNew Providers Facilitate Access to Diverse and Hard-to-Reach Populations and Support Complex Custom ProjectsLEXINGTON, Mass., Oct. 26, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for biomedical research with a network of healthcare specimen providers, announced today that the Company has added several new infectious disease specimen providers to its global supply network. These |
iSpecimen Preannounces Third Quarter 2023 Revenue Increase of 60-70% SequentiallyManagement to Host Third Quarter 2023 Conference Call on Thursday, November 2, 2023LEXINGTON, Mass., Oct. 23, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today preliminary financial results for the third quarter of 2023. The Company expects third quarter 2023 revenue to be between $2.6 to $2.8 milli |
iSpecimen Launches Next-Day Quote Service for Medical Researchers and Biospecimen ProvidersAccurate Pricing Delivered Within 24 Hours to Enhance the Customer Journey and Accelerate Medical ResearchLEXINGTON, Mass., Sept. 28, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for biomedical research with a network of healthcare specimen providers, announced today that the Company has added a new next-day quote service for researchers and providers. Tailored to accelerate the |
Insider Buying: Benjamin Bielak Acquires 18,000 Shares of iSpecimen IncIn a recent development, Benjamin Bielak, Chief Information Officer & Secretary of iSpecimen Inc (NASDAQ:ISPC), purchased 18,000 shares of the company on September 14, 2023. |
iSpecimen Expands Provider Network to Enhance Support for Women’s Health ResearchAdditional Providers Increase Biospecimen Access for Researchers Focused on Cervical, Uterine and Breast Cancers, as well as Reproductive Health, Cardiovascular Disease, Autoimmune Disorders and STIsLEXINGTON, Mass., Sept. 13, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today that the Company has re |
Biotech services company iSpecimen company lays off one-quarter of its staffLexington-based iSpecimen Inc. (Nasdaq: ISPC) announced the layoffs as part of broader "organizational changes" late Wednesday. Around six of the people being let go are based in Massachusetts, according to a statement from CEO Tracy Curley sent by spokesperson Raquel Cona. |
iSpecimen Announces Organizational Changes to Enhance Operational Efficiencies and Drive ProfitabilityCompany to Focus on Core Revenue Drivers, New Revenue Growth Opportunities from Recently Launched Sequencing Procurement Program and Expense ReductionsLEXINGTON, Mass., Sept. 06, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today that the Board of Directors has approved an organizational restructurin |
iSpecimen Launches New Virtual Cancer Sequencing Procurement ProgramProgram to Provide Cancer Researchers with Direct Access to Highly Sought Donor Tumor Tissue Samples Virtual Inventory Comprised of Formalin-Fixed, Paraffin-Embedded (FFPE) Samples Screened for Mutations LEXINGTON, Mass., Aug. 30, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today the launch of a new |